Edetic Acid

Edetic Acid

SCHEMBL1006496

O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.OCCN(CCO)CCO

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.74
EYA2 O00167 1/20 0.74
APP P05067 1/20 0.74
ACE P12821 1/20 0.74
ALOX15 P16050 3/20 0.70
KDM4E B2RXH2 2/20 0.70
BLM P54132 2/20 0.70
PMP22 Q01453 2/20 0.70
LMNA P02545 2/20 0.70
TSHR P16473 2/20 0.70
CYP2C19 P33261 2/20 0.70
CHRM2 P08172 1/20 0.70
ADRA2A P08913 1/20 0.70
DRD1 P21728 1/20 0.70
SLC6A2 P23975 1/20 0.70
SLC6A4 P31645 1/20 0.70
ADRA1A P35348 1/20 0.70
DRD3 P35462 1/20 0.70
SLC6A3 Q01959 1/20 0.70
HRH3 Q9Y5N1 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL8611926 1.00 TDP1 (0.74) TDP1EYA2APPACEALOX15
Edetic Acid SCHEMBL10949095 1.00 TDP1 (0.74) TDP1EYA2APPACEALOX15
SCHEMBL25851254 1.00 TDP1 (0.74) TDP1EYA2APPACEALOX15
SCHEMBL5097424 1.00 TDP1 (0.74) TDP1EYA2APPACEALOX15
Hydrochloric Acid SCHEMBL9008883 0.97 TDP1 (0.70) TDP1EYA2APPACEALOX15
Edetic Acid SCHEMBL4015979 0.97 TDP1 (0.78) TDP1EYA2APPACEALOX15
SCHEMBL24758890 0.95 ALOX15 (0.79) TDP1EYA2APPACEALOX15
SCHEMBL143335 0.95 ALOX15 (0.79) TDP1EYA2APPACEALOX15
SCHEMBL8612236 0.95 ALOX15 (0.79) TDP1EYA2APPACEALOX15
Edetic Acid SCHEMBL1768177 0.95 ALOX15 (0.79) TDP1EYA2APPACEALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4593966-A2 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, Inc. (US) 2025-08-06 EP claimed
US-20240342070-A1 Topical Compositions and Formulations with Multifunctional Actions, Including Activity Against Parasites BIOSAFE TECHNOLOGIES, INC. (US) 2024-10-17 US claimed
EP-4384138-A1 TOPICAL COMPOSITIONS AND FORMULATIONS WITH MULTIFUNCTIONAL ACTIONS, INCLUDING ACTIVITY AGAINST PARASITES BioSafe Technologies, Inc. (US) 2024-06-19 EP claimed
EP-3160487-B1 ANTIMICROBIAL COMPOSITIONS FOR THE VETERINARY FIELD Icf Srl (IT) 2024-05-01 EP claimed
US-20240108560-A1 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, INC. 2024-04-04 US claimed
WO-2024073683-A2 HAIR DEMINERALIZER COMPOSITION, METHODS AND USES THEREOF K18, INC. (US) 2024-04-04 WO claimed
EP-4294418-A1 NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS Lyrus Life Sciences Pvt. LTD. (IN) 2023-12-27 EP claimed
EP-3829535-B1 COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF CUTANEOUS AFFECTIONS Icf Srl (IT) 2023-11-08 EP claimed
EP-4208578-A1 ECOLOGICAL RELEASE OF ELEMENTS AND DEGRADATION OF ORGANICS USING HETEROTROPHIC MICROORGANISMS OUT OF MULTIPLE CARRIER MATERIALS Styriakova, Darina (SK) 2023-07-12 EP claimed
CN-115791858-A Method for determining constant thorium in associated radioactive ore by strontium internal standard-XRF solution method 核工业二三0研究所 2023-03-14 CN claimed
WO-2023018842-A1 TOPICAL COMPOSITIONS AND FORMULATIONS WITH MULTIFUNCTIONAL ACTIONS, INCLUDING ACTIVITY AGAINST PARASITES BIOSAFE TECHNOLOGIES, INC. (US) 2023-02-16 WO claimed
WO-2022175856-A1 NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS LYRUS LIFE SCIENCES PVT LTD (IN) 2022-08-25 WO claimed
EP-3964593-A1 ECOLOGICAL RELEASE OF ELEMENTS AND DEGRADATION OF ORGANICS USING HETEROTROPHIC MICROORGANISMS OUT OF MULTIPLE CARRIER MATERIALS Styriakova, Darina (SK) 2022-03-09 EP claimed
US-6054450-A SOLUTION OF ZINC PYRITHIONE IN N-ACYLETHYLENEDIAMINETRIACETATE. PACIFIC CORPORATION (KR) 2000-04-25 US claimed
WO-2026104587-A1 CYCLIC BORONIC ACID ESTERS USEFUL AS ADJUVANTS IN THE TREATMENT OF BACTERIAL INFECTIONS ADJUTEC PHARMA AS (NO) 2026-05-21 WO disclosed
US-12616675-B1 Antifungal liquid and antifungal gel The Tetra Corporation (US) 2026-05-05 US disclosed
EP-4731181-A1 TOPICAL COMPOSITIONS FOR TREATING COLD SORES Haleon UK IP Limited (GB) 2026-04-29 EP disclosed
US-4835149-A AMINE, AMINOCARBOXYLIC ACID BASF CORPORATION (US) 1989-05-30 US disclosed
EP-0268911-A2 Solubilization of salts of pyridine-2-thiol-1-oxide BASF Corporation (US) 1988-06-01 EP disclosed
US-4330291-A Nitrated coupler compounds useful in direct dyeing and simultaneous oxidation and direct dyeing of keratinic fibers SOCIETE ANONYME DITE: L'OREAL (FR) 1982-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616675-B1 Antifungal liquid and antifungal gel SORD, MANBA, CHKB TDP1 3936/4885EYA2 2326/4885APP 2179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.